Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | March 4, 2005 |
| Target | Closure Medical |
| Sector | Medical Products |
| Buyer(s) | Johnson & Johnson |
| Deal Type | Add-on Acquisition |
| Deal Value | 370M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1886 |
| Sector | Consumer Products |
| Employees | 132,000 |
| Revenue | 88.8B USD (2024) |
Johnson & Johnson is a global healthcare conglomerate that operates across three primary sectors: Pharmaceuticals, Medical Devices, and Consumer Health. In Pharmaceuticals, it develops treatments for a variety of conditions, including immunology, oncology, and infectious diseases. The Medical Devices segment offers a range of equipment and devices for healthcare professionals, encompassing orthopedics, surgery, and cardiovascular care. Its Consumer Health division markets a wide array of products, spanning baby care, oral care, skin care, over-the-counter drugs, and women's health, with popular brands such as Band-Aid, Tylenol, and Neutrogena under its umbrella. Johnson & Johnson was formed in 1886 and is based in New Brunswick, New Jersey.
| Deal Context for Buyer | # |
|---|---|
| Overall | 12 of 47 |
| Sector: Medical Products | 7 of 17 |
| Type: Add-on Acquisition | 8 of 39 |
| State: North Carolina | 1 of 2 |
| Country: United States | 12 of 39 |
| Year: 2005 | 1 of 3 |
| Size (of disclosed) | 25 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2002-11-13 |
OraPharma
Horsham, Pennsylvania, United States OraPharma, Inc. is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of periodontal disease at various phases of progression. |
Buy | $85M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-03-09 |
TransForm Pharmaceuticals
Lexington, Massachusetts, United States TransForm Pharmaceuticals, Inc., a privately held company that specializes in the discovery of superior formulations and novel crystalline forms of drug molecules. Formed in 1999, TransForm currently has approximately 80 employees. |
Buy | $230M |
